AMG 562
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AMG 562, covering 2024-03-22 to 2024-03-22. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of AMG 562 in Subjects With r/r Diffuse Large B-cell Lymphoma, Mantle Cell Lymphoma, or Follicular Lymphoma [Phase 1]